Edition:
United Kingdom

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

6.55USD
22 Jun 2018
Change (% chg)

$0.40 (+6.50%)
Prev Close
$6.15
Open
$6.20
Day's High
$6.75
Day's Low
$6.10
Volume
7,229,488
Avg. Vol
749,634
52-wk High
$10.65
52-wk Low
$1.55

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 6.25 -0.383
FY 2017 Dec '17 20.41 0.572
Sep '17 121.91 -0.027
Jun '17 4.66 -0.202
Mar '17 4.87 -0.453
FY 2016 Dec '16 4.02 -0.204
Sep '16 2.24 0.239
Jun '16 0.90 -0.931
Mar '16 0.99 -0.412
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 2.83 3.15 2.50 5.80
Quarter Ending Sep-18 2 3.84 4.00 3.68 5.90
Year Ending Dec-18 2 17.41 17.75 17.08 18.23
Year Ending Dec-19 2 47.21 62.20 32.22 --
Earnings (per share)
Quarter Ending Jun-18 2 -0.20 -0.18 -0.22 -0.19
Quarter Ending Sep-18 2 -0.19 -0.18 -0.20 -0.19
Year Ending Dec-18 2 -0.93 -0.88 -0.97 -1.04
Year Ending Dec-19 2 -0.60 -0.52 -0.68 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 82.81 32.74
P/E High - Last 5 Yrs. -- 289.15 45.73
P/E Low - Last 5 Yrs. -- 90.24 24.23
Beta 1.68 0.91 0.88
Price to Sales (TTM) 8.72 109.18 5.71
Price to Book (MRQ) 1.49 13.44 5.37
Price to Tangible Book (MRQ) -- 13.96 6.94
Price to Cash Flow (TTM) -- 70.39 23.32
% Owned Institutions 16.91 13.84 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.50
Dividend Yield - 5 Year Avg -- 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) -- 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 417.18 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago 264.92 77.35 5.68
Sales - 5 Yr. Growth Rate 72.80 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 78.33 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago 67.70 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate 45.51 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.83 2.19
Current Ratio (MRQ) 0.76 5.26 2.98
LT Debt to Equity (MRQ) 28.72 24.54 12.19
Total Debt to Equity (MRQ) 28.72 26.17 16.46
Interest Coverage (TTM) -39.19 -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 87.11 40.81 54.46
Gross Margin - 5 Yr. Avg. -- 51.76 52.22
EBITD Margin (TTM) -440.86 -- --
EBITD - 5 Yr. Avg -1,306.82 -564.12 10.98
Operating Margin (TTM) -396.65 -706.11 4.74
Operating Margin - 5 Yr. Avg. -1,318.88 -585.15 6.41
Pre-Tax Margin (TTM) -255.23 -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -804.66 -588.45 6.83
Net Profit Margin (TTM) -229.98 -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -996.11 -591.46 3.10
Effective Tax Rate (TTM) -- 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 102,604 22,312,275 846,855,748
Net Income/Employee (TTM) -235,968 2,947,385 99,619,396
Receivable Turnover (TTM) 9.74 19.92 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.04 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -9.87 -0.70 10.95
Return on Assets - 5 Yr. Avg. -22.28 -0.06 12.32
Return on Investment (TTM) -12.13 2.00 14.38
Return on Investment - 5 Yr. Avg. -24.93 2.81 16.11
Return on Equity (TTM) -29.69 3.49 16.08
Return on Equity - 5 Yr. Avg. -45.57 4.33 17.41
  1 Year 3 Year 5 Year
Sales % 77.60 160.69 72.80
EPS (TTM) % 2.53 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sorrento Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.86 -0.69 99 53
13 Week -7.69 -12.19 74 69
26 Week -40.98 -45.47 28 77
52 Week -76.62 -80.19 9 48
YTD -63.27 -67.74 12 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.97%
# of Holders: 102
Total Shares Held: 24,217,907
3 Mo. Net Change: 13,021,080
# New Positions: 38
# Closed Positions: 9
# Increased Positions: 66
# Reduced Positions: 26
# Net Buyers: 40
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.